single-cell cytokine analysis allows detection of cervical T-cell responses against human papillomavirus type 16 L1 in women infected with genital HPV
Jo-Ann S. Passmore
Department of Clinical Laboratory Sciences, Division of Medical Virology, University of Cape Town and Groote Schuur Hospital, Observatory, Cape Town, South Africa
Search for more papers by this authorVanessa C. Burch
Department of Medicine, University of Cape Town and Groote Schuur Hospital, Observatory, Cape Town, South Africa
Search for more papers by this authorEnid G. Shephard
Department of Medicine, University of Cape Town and Groote Schuur Hospital, Observatory, Cape Town, South Africa
Search for more papers by this authorDianne J. Marais
Department of Clinical Laboratory Sciences, Division of Medical Virology, University of Cape Town and Groote Schuur Hospital, Observatory, Cape Town, South Africa
Search for more papers by this authorBruce Allan
Department of Clinical Laboratory Sciences, Division of Medical Virology, University of Cape Town and Groote Schuur Hospital, Observatory, Cape Town, South Africa
Search for more papers by this authorPatti Kay
Department of Clinical Laboratory Sciences, Division of Medical Virology, University of Cape Town and Groote Schuur Hospital, Observatory, Cape Town, South Africa
Search for more papers by this authorRobert C. Rose
Department of Medicine, Microbiology and Immunology, University of Rochester School of Medicine and Dentistry, Rochester, New York, New York
Search for more papers by this authorCorresponding Author
Anna-Lise Williamson
Department of Clinical Laboratory Sciences, Division of Medical Virology, University of Cape Town and Groote Schuur Hospital, Observatory, Cape Town, South Africa
Division of Medical Virology, Department of Clinical Laboratory Scineces, Faculty of Health Sciences, University of Cape Town and Groote Schuur Hospital, Anzio Road, Observatory, 7925, Cape Town, South Africa.===Search for more papers by this authorJo-Ann S. Passmore
Department of Clinical Laboratory Sciences, Division of Medical Virology, University of Cape Town and Groote Schuur Hospital, Observatory, Cape Town, South Africa
Search for more papers by this authorVanessa C. Burch
Department of Medicine, University of Cape Town and Groote Schuur Hospital, Observatory, Cape Town, South Africa
Search for more papers by this authorEnid G. Shephard
Department of Medicine, University of Cape Town and Groote Schuur Hospital, Observatory, Cape Town, South Africa
Search for more papers by this authorDianne J. Marais
Department of Clinical Laboratory Sciences, Division of Medical Virology, University of Cape Town and Groote Schuur Hospital, Observatory, Cape Town, South Africa
Search for more papers by this authorBruce Allan
Department of Clinical Laboratory Sciences, Division of Medical Virology, University of Cape Town and Groote Schuur Hospital, Observatory, Cape Town, South Africa
Search for more papers by this authorPatti Kay
Department of Clinical Laboratory Sciences, Division of Medical Virology, University of Cape Town and Groote Schuur Hospital, Observatory, Cape Town, South Africa
Search for more papers by this authorRobert C. Rose
Department of Medicine, Microbiology and Immunology, University of Rochester School of Medicine and Dentistry, Rochester, New York, New York
Search for more papers by this authorCorresponding Author
Anna-Lise Williamson
Department of Clinical Laboratory Sciences, Division of Medical Virology, University of Cape Town and Groote Schuur Hospital, Observatory, Cape Town, South Africa
Division of Medical Virology, Department of Clinical Laboratory Scineces, Faculty of Health Sciences, University of Cape Town and Groote Schuur Hospital, Anzio Road, Observatory, 7925, Cape Town, South Africa.===Search for more papers by this authorAbstract
Specific types of human papillomavirus (HPV) are known to play a causal role in the development of cervical cancer, with human papillomavirus type 16 (HPV-16) identified as the predominant type. Despite this, little is known about cervical immune responses to this pathogen. The aim of this study was to assess the feasibility of cervical cytobrush sampling and single-cell cytokine staining to investigate cervical lymphocyte-specific cytokine responses to HPV-16 antigens. Of eighteen women recruited into the study, five were HPV DNA positive at the cervix (current exposure) and a further five had circulating antibodies to HPV-16 (previous exposure). Cervical lymphocytes, isolated from the five HPV DNA-positive women, two HPV DNA-negative controls, and one woman with circulating HPV-16 antibodies were assessed for HPV-specific responses using intracellular staining for interferon-γ (IFN-γ) and interleukin-4 (IL-4). We demonstrate that both CD4+ and CD8+ cervical T lymphocytes, harvested from noninfected and infected subjects, produce these cytokines in response to nonspecific stimulation. However, antigen-specific (HPV-16 L1) IFN-γ production by CD4+ and CD8+ cervical T lymphocytes is only detectable in women exposed currently or previously to HPV-16. This is the first time that antigen-specific cytokine responses of mucosal lymphocytes, obtained from a site of HPV infection, have been demonstrated. This finding clearly illustrates the use of intracellular cytokine staining for investigation of low precursor frequency single-cell antigen-specific responses in lymphocytes harvested from mucosal sites with HPV infection. J. Med. Virol. 67:234–240, 2002. © 2002 Wiley-Liss, Inc.
REFERENCES
- Bontkes HJ, de Gruijl TD, Walboomers JMM, Schiller JT, Dillner J, Helmerhorst TJM, Verheijen RHM, Scheper RJ, Meijer CJLM. 1999. Immune responses against human papillomavirus type 16 virus-like particles in a cohort study of women with cervical intraepithelial neoplasia: systemic but not local IgA responses correlate with clearance of HPV-16. J Gen Virol 80: 409–417.
- Bosch FX, Manos MM, Munoz N, Sherman M, Jansen AM, Peto J, Schiffman MH, Moreno V, Kurman R, Shah KV. 1995. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. J Natl Cancer Inst 87: 796–802.
- Boyum A. 1968. Separation of leukocytes from blood and bone marrow. Scand J Clin Lab Invest 21(suppl): 97.7.
- Crowley-Nowick PA, Bell M, Edwards RP, McCallister D, Gore H, Kanbour-Shakir A, Mestecky J, Partridge EE. 1995. Normal uterine cervix: characterization of isolated lymphocyte phenotypes and immunoglobulin secretion. Am J Reprod Immunol 34: 241–247.
- de Gruijl TD, Bontkes HJ, Walboomers JMM, Coursaget P, Stukart MJ, Dupuy C, Kueter E, Verheijen RHM, Helmerhorst TJM, Duggan-Keen MF, Stern PL, Meijer CJLM, Scheper RJ. 1999. Immune responses against HPV type 16 virus-like particles in a cohort study of women with cervical intraepithelial neoplasia: differential T helper and IgG responses in relation to HPV infection and disease outcome. J Gen Virol 80: 399–408.
- Edwards JN, Morris HB. 1985. Langerhans cells and lymphocyte subsets in the female genital tract. Br J Obstet Gynaecol 92: 974–982.
- Evander M, Edland K, Gustafsson A, Jonsson M, Karlsson R, Rylander E, Wadell G. 1995. Human papillomavirus infection is transient in young women: a population-based cohort study. J Infect Dis 171: 1026–1030.
- Evans TG, Bonnez W, Rose RC, Koenig S, Demeter L, Suzich JA, O'Brien D, Campbell M, White WI, Balsley J, Reichman RC. 2001. A phase I study of a recombinant virus-like particle vaccine against HPV type 11 in healthy adult volunteers. J Infect Dis 183: 1485–1493.
- Frazer IH. 1996. Immunology of papillomavirus infection. Curr Opin Immunol 8: 484–491.
- Frazer IH, Tindle RW. 1992. Cell-mediated immunity to papillomaviruses. Papillomavirus Rep 3: 53–58.
- Giannini SL, Al-Saleh W, Piron H, Jacobs N, Doyen J, Boniver J, Delvenne P. 1998. Cytokine expression in squamous intraepithelial lesions of the uterine cervix: implications for the generation of local immunosuppression. Clin Exp Immunol 113: 183–189.
- Hagensee ME, Koutsky LA, Lee SK, Grubert T, Kuypers J, Kiviat NB, Galloway DA. 2000. Detection of cervical antibodies to human papillomavirus type 16 capsid antigens in relation to detection of HPV-16 DNA and cervical lesions. J Infect Dis 181: 1234–1239.
- Ho GY, Bierman R, Beardsley L, Chang CJ, Burk RD. 1998. Natural history of cervicovaginal papillomavirus infection in young women. N Engl J Med 338: 423–428.
- Hussain LA, Kelly CG, Fellowes R, Hecht EM, Wilson J, Chapman M, Lehner T. 1992. Expression and gene transcript of Fc receptors for IgG, HLA class II antigens and langerhans cells in human cervicovaginal epithelium. Clin Exp Immunol 90: 530–538.
- Kuhn L, Denny L, Pollack A, Lorincz A, Richart RM, Wright TC. 2000. Human papillomavirus DNA testing for cervical cancer screening in low-resource settings. J Natl Cancer Inst 92: 818–825.
- Kutteh WH, Edwards RP, Menge AC, Mestecky J. 1993. IgA immunity in female reproductive tract secretions. In: PD Griffen, P Johnson, eds. Local immunity in reproduction tract tissues. New Delhi: Oxford University Press. p 229–243.
- Lohman BL, Miller CJ, McChesney MB. 1995. Antiviral cytotoxic T lymphocytes in vaginal mucosa of simian immunodeficiency virus-infected rhesus macaques. J Immunol 155: 5855–5860.
- Luxton JC, Rose RC, Coletart T, Wilson P, Shephard PS. 1997. Serological and T helper cell responses to HPV type 16 L1 in women with cervical dysplasia or cervical carcinoma and in healthy controls. J Gen Virol 78: 917–923.
- Manos MM, Ting Y, Wright DK, Lewis AJ, Broker TR, Wolinsky SM. 1989. Use of polymerase chain reaction amplification for the detection of genital HPV. Cancer Cells 7: 209–214.
-
Marais DJ,
Rose RC,
Williamson AL.
1997.
Age distribution of antibodies to HPV in children, women with CIN, and blood donors from South Africa.
J Med Virol
51:
126–131.
10.1002/(SICI)1096-9071(199702)51:2<126::AID-JMV7>3.0.CO;2-9 CAS PubMed Web of Science® Google Scholar
- Marais DJ, Best JM, Rose RC, Keating P, Soeters R, Denny L, Dehaeck CMC, Nevin J, Kay P, Passmore JS, Williamson AL. 2001. Oral antibodies to HPV type 16 in women with cervical neoplasia. J Med Virol 65: 149–154.
- McKenzie J, King A, Hare J, Fulford T, Wilson B, Stanley M. 1991. Immunocytochemical characterization of large granular lymphocytes in normal cervix and HPV associated disease. J Pathol 165: 75–80.
- Moscicki AB, Shiboscki S, Broering J, Powell K, Clayton L, Jay N, Darragh TM, Brescia R, Kanowitz S, Miller B, Stone J, Hanson E, Palefsky J. 1995. The natural history of human papillomavirus infection as measured by repeated DNA testing in adolescent and young women. J Pediatr 132: 277–284.
- Musey L, Hu YX, Eckert L, Christensen M, Karchmer T, McElrath MJ. 1997. HIV-1 induces cytotoxic T lymphocytes in the cervix of infected woman. J Exp Med 185: 293–303.
- NIH. 1996. Cervical cancer. Consensus statement no. 14. Bethesda, MD: National Institutes of Health; p 1–38.
- Scott M, Stites DP, Moscicki AB. 1999. Th1 cytokine patterns in cervical human papillomavirus infection. Clin Diagn Lab Immunol 6: 751–755.
- Scott M, Nakagawa M, Moscicki AB. 2001. Cell-mediated immune response to HPV infection. Clin Diagn Lab Immunol 8: 209–220.
- Shepherd PS, Luxton J. 1999. T cell responses to HPV in cervical dysplasia. Papillomavirus Rep 10: 53–59.
- Shepherd PS, Rowe AJ, Cridland JC, Coletart T, Wilson P, Luxton JC. 1996. Proliferative T cell response to HPV type 16 L1 peptides in patients with cervical dysplasia. J Gen Virol 77: 593–602.
- Strang G, Hickling JK, McIndoe GAJ, Howland K, Wilkinson D, Ikeda H, Rothbard JB. 1990. Human T cell responses to HPV type 16 L1 and E6 synthetic peptides: identification of T cell determinants, HLA-DR restriction and virus type specificity. J Gen Virol 71: 423–431.
- van den Brule AJC, Claas ECJ, du Maine M, Melchers WTG, Helmerhorst T, Quint WGV, Lindeman J, Meijer CJLM, Walboomers JMM. 1989. Use of anticontamination primers in the PCR reaction for detection of HPV genotypes in cervical scrapes and biopsies. J Med Virol 29: 20–27.
- Wang Z, Hansson BG, Forslund O, Dillner L, Sapp M, Schiller JT, Bjerre B, Dillner J. 1996. Cervical mucous antibodies against human papillomavirus type 16, 18 and 33 capsids in relation to presence of viral DNA. J Clin Microbiol 34: 3056–3062.
- White D, Crassi KM, Givan AL, Stern JE, Gonzalez JL, Memoli VA, Green WR, Wira CR. 1997a. CD3+CD8+ CTL activity within the human female reproductive tract. Influence of stage of the menstrual cycle and menopause. J Immunol 158: 3017–3027.
- White D, Yeaman GR, Givan AL, Wira CR. 1997b. Mucosal immunity in the human female reproductive tract: CTL function in the cervix and vagina of premenopausal and postmenopausal women. Am J Reprod Immunol 37: 30–38.
- Williamson AL, Brink NS, Dehaeck CMC, Ovens S, Soeters R, Rybicki EP. 1994. Typing of HPV in cervical carcinoma biopsies from Cape Town. J Med Virol 43: 231–237.
- Zhou J, Lui WJ, Peng SW, Frazer I. 1999. Papillomavirus capsid protein expression level depends on the match between codon usage and tRNA availability. J Virol 73: 4972–4982.